UNION CITY, Calif.--(BUSINESS WIRE)--Celltheon today announced the commercial launch of its CHO-K1 based OmniCHO™ Transient Expression Kit, a breakthrough technology poised to transform preclinical ...

The global mammalian transient protein expression market is on a robust growth trajectory, projected to reach USD 762.34 million in 2024 and expand at a CAGR of 5.5% over the next decade, ultimately ...